BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33924646)

  • 1. Cell-Mediated Therapies to Facilitate Operational Tolerance in Liver Transplantation.
    Ellias SD; Larson EL; Taner T; Nyberg SL
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T-cell therapy in liver transplantation.
    Whitehouse GP; Hope A; Sanchez-Fueyo A
    Transpl Int; 2017 Aug; 30(8):776-784. PubMed ID: 28608637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies.
    Du X; Chang S; Guo W; Zhang S; Chen ZK
    Front Immunol; 2020; 11():1326. PubMed ID: 32670292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives.
    Wang P; Jiang Z; Wang C; Liu X; Li H; Xu D; Zhong L
    Front Immunol; 2020; 11():1723. PubMed ID: 33013824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular strategies to induce immune tolerance after liver transplantation: Clinical perspectives.
    Zhou AW; Jin J; Liu Y
    World J Gastroenterol; 2024 Apr; 30(13):1791-1800. PubMed ID: 38659486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant Tolerance Induction: Insights From the Liver.
    Dai H; Zheng Y; Thomson AW; Rogers NM
    Front Immunol; 2020; 11():1044. PubMed ID: 32582167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects.
    Liu XQ; Hu ZQ; Pei YF; Tao R
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):12-33. PubMed ID: 23392795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for Liver Transplantation Tolerance.
    Cvetkovski F; Hexham JM; Berglund E
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial Monitoring of Immune Markers Being Represented Regulatory T Cell/T Helper 17 Cell Ratio: Indicating Tolerance for Tapering Immunosuppression after Liver Transplantation.
    Jhun J; Lee SH; Lee SK; Kim HY; Jung ES; Kim DG; Choi J; Bae SH; Yoon SK; Chung BH; Yang CW; Cho ML; Choi JY
    Front Immunol; 2018; 9():352. PubMed ID: 29545795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.
    Todo S; Yamashita K; Goto R; Zaitsu M; Nagatsu A; Oura T; Watanabe M; Aoyagi T; Suzuki T; Shimamura T; Kamiyama T; Sato N; Sugita J; Hatanaka K; Bashuda H; Habu S; Demetris AJ; Okumura K
    Hepatology; 2016 Aug; 64(2):632-43. PubMed ID: 26773713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance in liver transplantation: Biomarkers and clinical relevance.
    Baroja-Mazo A; Revilla-Nuin B; Parrilla P; Martínez-Alarcón L; Ramírez P; Pons JA
    World J Gastroenterol; 2016 Sep; 22(34):7676-91. PubMed ID: 27678350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: a scoping review protocol.
    Appenzeller-Herzog C; Hartleif S; Vionnet J
    F1000Res; 2019; 8():2059. PubMed ID: 32399186
    [No Abstract]   [Full Text] [Related]  

  • 13. Biomarkers of immune tolerance in liver transplantation.
    Vionnet J; Sánchez-Fueyo A
    Hum Immunol; 2018 May; 79(5):388-394. PubMed ID: 29462637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance.
    de la Garza RG; Sarobe P; Merino J; Lasarte JJ; D'Avola D; Belsue V; Delgado JA; Silva L; Iñarrairaegui M; Sangro B; Sola JJ; Pardo F; Quiroga J; Herrero JI
    Liver Transpl; 2013 Sep; 19(9):937-44. PubMed ID: 23784747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Therapy as a Tool for Induction of Immunological Tolerance after Liver Transplantation.
    Kholodenko IV; Kholodenko RV; Lupatov AY; Yarygin KN
    Bull Exp Biol Med; 2018 Aug; 165(4):554-563. PubMed ID: 30121913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal of immunosuppression in liver transplantation and the mechanism of tolerance.
    Zhang CX; Wen PH; Sun YL
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):470-6. PubMed ID: 26459722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaching the promise of operational tolerance in clinical transplantation.
    Bishop GA; Ierino FL; Sharland AF; Hall BM; Alexander SI; Sandrin MS; Coates PT; McCaughan GW
    Transplantation; 2011 May; 91(10):1065-74. PubMed ID: 21544029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of immune tolerance in liver transplantation].
    Pons JA; Revilla-Nuin B; Ramírez P; Baroja-Mazo A; Parrilla P
    Gastroenterol Hepatol; 2011 Mar; 34(3):155-69. PubMed ID: 21376423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous and induced tolerance for liver transplant recipients.
    Feng S
    Curr Opin Organ Transplant; 2016 Feb; 21(1):53-8. PubMed ID: 26709575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells for tolerance induction in organ transplantation.
    Casiraghi F; Perico N; Remuzzi G
    Hum Immunol; 2018 May; 79(5):304-313. PubMed ID: 29288697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.